254TiP ENGOT-cx11/KEYNOTE-A18: A phase III, randomized, double-blind study of pembrolizumab with chemoradiotherapy in patients with high-risk locally advanced cervical cancer. - Lorusso, D.; Xiang, Y.; Colombo, N.; Coleman, R.; Randall, L.; Duska, L.; Hasegawa, K.; Nogueira-Rodrigues, A.; Cibula, D.; Mirza, M.R.; You, B.; Oaknin, A.; et al. (Annals of Oncology, 2020)